Smartphone Screening for Irregular Heartbeat to Help Prevent Stroke in Older Adults
Tests smartphone screening for atrial fibrillation to prevent stroke in older adults.
Plain-language title generated from the registry record
Registry title: Digital Screening for Atrial Fibrillation to Prevent Stroke
Key facts
- Where
- Innsbruck, AustriaSee the site
Where in Austria
- Department of Internal Medicine III, Medical University InnsbruckInnsbruck, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medical University Innsbruck
- Trial code
- NCT07684053
- Record updated
- 6 July 2026
- Original description
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.Read full original descriptionShow less
Digital Screening for Atrial Fibrillation to Prevent Stroke: The Randomized Austrian Digital Heart Study
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
Inclusion: Age ≥ 65 years; Policyholder in Austria (active unique social insurance number); Written electronic informed consent Exclusion Criteria; Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED).